BPC-157
None of the 30 tracked EU+ jurisdictions lists BPC-157 as authorised. This page summarises approval status, brands, shortages and recent regulatory changes by country.
Related regulatory compounds
Country-by-country approval and availability
30 EU+ jurisdictions covered.
Strict customs scrutiny; frequent seizures.
Updates for BPC-157
2024-09-12 · 🇩🇪 Germany
BfArM: enhanced customs scrutiny for BPC-157
New Zoll directive to seize research peptide parcels from non-EU sources.
What is being studied right now
Entries from public research registries. Titles are reproduced as published, with a link to the source. No outcomes, conclusions or comparisons are included.
Ongoing clinical trials
Source: ClinicalTrials.gov
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain Confirmed by MRI
NCT07437547 · Recruiting · Phase 2 · Sponsor: Hudson Biotech
- Impact of BPC-157 on Recovery From Rotator Cuff Repair Surgery
NCT07803250 · Not yet recruiting · Phase 1 · Sponsor: University of Arkansas
- Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source
NCT02637284 · Unknown (last update 2016) · Phase 1 · Sponsor: PharmaCotherapia d.o.o.
Recent publications
Source: PubMed
- BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
review · Pharmaceutics · 2026 · PMID 42198317 · DOI
- Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury
in animals · Scientific Reports · 2026 · PMID 42204242 · DOI
- Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats - A Cytoprotection Approach
in animals · Pharmaceuticals · 2026 · PMID 42356491 · DOI
- BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase
laboratory · International Journal of Molecular Sciences · 2026 · PMID 42278509 · DOI
- Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats
in animals · Journal of Physiology and Pharmacology · 2026 · PMID 42533460 · DOI
Registries last checked: 2026-09-28